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Hydrogen Sulfide:  
not just a malodorous gas?
Athanasios G. Yalouris, MD
Hydrogen sulfide or H2S (greek: υδρόθειον) is a colorless gas with a characteristic 
unpleasant smell. It emerges from volcanoes (Figure 1) and several natural springs. 
It is also produced through the anaerobic breakdown of organic material by sulfate-
reducing bacteria. For many years, our knowledge concerning its effects on human 
beings was limited to its toxicity. Hydrogen sulfide is a highly toxic gas, disturbing the 
function of several organs and mainly the nervous system. Inhaled H2S is absorbed 
through the alveolar epithelium. The safe levels for H2S concentration in the air are 
defined as 10-20 ppm (parts per million: it means concentration of 1 unit of a certain 
substance in a total of a million units). It is well known that when humans are exposed 
to relatively high H2S levels -occurring mainly in industrial environments, such as tan-
neries, mining, paper mills and petroleum refineries- several symptoms may appear, 
ranging from irritation of the eyes and mucus membranes (in lower toxic concentra-
tions) to pulmonary injuring and even loss of consciousness and cardiopulmonary ar-
rest, in higher concentrations. Hydrogen sulfide is considered lethal in concentrations 
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FigurE 1. Hydrogen sulfide emerging from the crater of a volcano in Nisyros, Greece 
(personal archive).
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of about 1000 ppm.1 
Until recently, we practically ignored any intervention 
of H2S in mammals’ physiology. An old publication of 1942 
claimed that incubation of rat liver homogenates with sulfur-
containing amino acids resulted in the production of hydrogen 
sulfide, probably through a liver transsulfuration pathway.2 
However, no mention was given to this observation at the 
time. Only 50 years later, it was proved that hydrogen sulfide 
is produced in mammalian cells and has a physiologic role as a 
signaling molecule1. So, it is now recognized as another gaso-
transmitter. Under this term, are included gaseous chemical 
compounds that are normally produced in the human tissues 
and act as transmitters in the nervous system and other organs. 
Such a role was already known for nitric monoxide (NO) 
-also produced by an amino acid, arginine- and carbon mon-
oxide (CO) -generated from haem. Gasotransmitters, unlike 
other neurotransmitters, cannot be stored in vesicles. Several 
sulphur-containing substances act as H2S pools, liberating it 
when needed.3
It is currently accepted that H2S is synthesized in several 
tissues through the action of three different enzymes that 
metabolize l-cysteine. They are cystathionine-β-synthase, 
cystathionine-γ-lyase and 3-mercaptopyruvate sulfurtrans-
ferase (which probably acts in collaboration with a fourth en-
zyme, cysteine aminotransferase).1 The first of these enzymes 
predominates in the brain and its activity can be modulated by 
CO and NO, indicating a collaboration of all three gasotrans-
mitters, at least in the brain. Cystathionine γ-lyase is the most 
inducible of all H2S-synthesizing enzymes, its expression being 
affected by several substances, such as tumor necrosis factor-α 
(TNF-α) and lipopolysaccharides (produced in inflammatory 
states), glucose, glucocorticoids and also by dietary restriction.3
The precise biological role of hydrogen sulfide is not yet 
clarified. An important action seems to be exerted on the 
mitochondria. It may offer electrons to the mitochondrial 
electron transport chain and also protect its structures through 
an antioxidant effect.4 It is also suggested that it may enhance 
the activity of some mitochondrial DNA repair enzymes, thus 
facilitating the repair of its injuries1. Experimental data have 
shown that in low (normal) concentrations, hydrogen sulfide 
stimulates ATP synthase and increases energy production,5 
while in higher concentrations it has the opposite effect, be-
cause of inhibition of cytochrome c oxidase. This inhibitory 
effect is further aggravated when pH shifts to acidosis.6 A same 
effect has also been shown for cyanide, but the difference is 
that in the case of H2S it is reversible. A hypothesis, that has 
to be proved, is that such an action may be protective for 
the cell by temporarily decreasing its oxygen demands under 
conditions of hypoxia.
H2S is currently considered to interfere in several normal 
procedures, including intrinsic regulation of vascular tone and 
blood pressure, the function of erection, angiogenesis, neuro-
transmission, sense of pain, cell reaction to stress, apoptosis, 
leucocyte function and inflammation.1 Of major importance is 
the fact that it increases levels of glutathione, one of the main 
defense mechanisms of the cell against oxidative stress, that is 
the harmful effect of free oxygen radicals produced in several 
abnormal conditions, as in inflammation or reperfusion injury.1
H2S has multiple protective effects on the cardiovascular 
system. It has a similar role to NO, causing vasorelaxation 
through sulfhydration of ATP-dependent potassium chan-
nels.3 It also seems to inhibit several mechanisms involved 
in atherogenesis, such as atherogenic modification of LDL, 
monocytes adhesion to the endothelial cells, foam cell forma-
tion and macrophage-derived inflammation, smooth muscle 
cell proliferation, neointimal hyperplasia, vascular calcifica-
tion, and thrombogenesis. Experimental data suggest that it 
may also decrease plasma levels of homocysteine, another 
substance involved in atherogenesis.7 
Several studies have shown that atherosclerosis is associ-
ated with vascular cystathionine γ-lyase deficiency, resulting 
in decreased production of H2S, although it is not yet clear 
whether this deficiency shares a considerable pathogenetic 
role in it.7 Experimental data in mice with genetic deletion 
of cystathionine γ-lyase fed an atherogenic diet, have shown 
accelerated atherosclerosis as compared to wild-type mice.8 
So, there is a possibility that pharmaceutical induction of this 
enzyme might prove beneficial in the prevention and treatment 
of atherosclerosis. Furthermore, experimental administration 
of sodium hydrosulfide (NaHS) -which acts as a H2S donor- 
was found to protect rat aorta from toxic factors contributing 
to the development of atherosclerosis.9 In another study 
with mice fed with an atherogenic diet, those with deficient 
cystathionine γ-lyase developed early fatty streak lesions in 
the aortic root, elevated plasma levels of total cholesterol, 
low-density lipoprotein cholesterol and homocysteine as well 
as enhanced aortic intimal proliferation. Treatment of these 
mice with NaHS prevented the development of accelerated 
atherosclerosis.8
Another possible action of H2S on atherogenesis is related 
to the oxidized low- density lipoprotein (ox-LDL), a form 
of LDL in which both the protein and the lipids undergo 
oxidative changes and form complex products. Ox-LDL has 
been considered to play a role in atherosclerosis since the 
observation that in vitro incubation of macrophages with oxi-
dized LDL -and not with native LDL- led to cholesterol ester 
accumulation. It sems that this damaged molecule of LDL 
is avidly scavenged and degraded by macrophages.10 In an in 
vitro study, it was shown that overexpression of cystathionine 
γ-lyase reduced the generation of ox-LDL-stimulated TNF-α 
in macrophages, while knockdown of this enzyme enhanced 
it. A subsequent study showed that both the levels of mRNA 
and protein expression of this enzyme and hydrogen sulfide 
production were decreased in ox-LDL-treated macrophages. 
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Exogenous administration of NaHS decreased the production 
of TNF-α and other proinflammatory molecules. Their con-
clusion was that ox-LDL may downregulate the H2S pathway, 
which plays an anti-inflammatory role in ox-LDL-stimulated 
macrophages.11
A study in apolipoprotein-E knockout mice -which are 
prone to atherogenesis- found decreased plasma H2S level 
and aortic H2S production as well as increased levels of intra-
cellular adhesion molecule-1 (ICAM-1) in plasma and aorta. 
When such mice were treated with NaHS, plasma H2S levels 
were increased, while the size of atherosclerotic plaque and 
plasma and aortic ICAM-1 levels were decreased. Thus, H2S 
showed an antiatherogenic effect and administration of NAHS 
seemed to prevent aortic atheromatosis.12 
Hydrogen sulfide has multiple roles in the central nervous 
system, either in  normal function or disease. The endogenous 
level of H2S in the brain is significantly higher than in other 
tissues. It is synthesized in astrocytes and released in response 
to neuronal excitation. It influences active synapses and this 
may mean a role in associative learning. There are also some 
indications that dysregulation of its metabolism may contrib-
ute to neurodegeneration. A deficient H2S signaling has been 
found in Alzheimer’s disease and Parkinson’s disease.3
It is also considered of special importance in secondary 
neuronal injury. After an event of acute neuronal insult (e.g. 
stroke, traumatic brain injury or spinal cord injury) several 
secondary neuronal injuries may follow, exacerbating the 
initial damage. Such injuries include microcirculation failure, 
glutamate-mediated excitotoxicity, oxidative stress, inflamma-
tory responses, neuronal apoptosis and calcium overload. Hy-
drogen sulfide activates smooth muscle cell plasma membrane 
ATP-sensitive potassium channels resulting in vasodilatation of 
cerebral vessels. It also induces glutamate uptake by astrocytes 
from the extracellular space, thus protecting the neurons from 
glutamate-mediated excitotoxicity. Further protection of neu-
rons is mediated through its anti-oxidant, anti-inflammatory 
and anti-apoptotic actions. The administration of H2S donors 
was found to have neuroprotective effects in mice. On the other 
hand, a possibly undesired effect of H2S may be enhancement 
of calcium overload.8 
Clinical observations have shown changes of H2S in sev-
eral abnormal conditions. In some of them (e.g., reperfusion 
injury, asthma, diabetic vascular complications, acute and 
chronic cardiac diseases, aging) there is a local or systemic 
H2S deficiency, due to either inhibition of its synthesis or 
increased consumption.1 In these cases, administration of 
H2S donors might be of some use. Such an administration 
has already been tested in animals with encouraging results 
in several disease models. Some of these donors are already 
investigated in clinical trials.13
On the contrary, in other abnormal conditions, such as 
malignancies, critically ill patients or patients with Down syn-
drome, there is an upregulation of hydrogen sulfide enzymes 
and so its levels are increased. In these cases, the possible utility 
of enzyme inhibitors is under consideration.1 
In an experimental procedure, hydrogen sulfide admin-
istration produced a hibernation-like state in rodents. The 
results were hypothermia and reduction in metabolic rate 
and oxygen demand. Such a state could be protective against 
hypoxia, as in ischemia-reperfusion injury.14 Combined with an 
antiinflammatory action, it can be beneficial in cases of acute 
lung injury, as it was shown with the intravenous administra-
tion of NaSH in an experimental model in anesthetized rats.15 
Potential therapeutic applications of hydrogen sulfide-induced 
hibernation are currently investigated.
However, the effects of hydrogen sulfide may not be always 
beneficial. A probably harmful biological role of H2S was 
detected in cystathionine γ-lyase deficient mice. When these 
mice were infected by Mycobacterium tuberculosis they had, 
as compared to the wild-type mice, a longer survival, reduced 
pathology and lower bacterial burdens in the lung, spleen, 
and liver. In vitro experiments confirmed that excessive H2S 
production -as happens in the normal mice- reduces hypoxia 
inducible factor 1 alpha (HIF-1α) levels, thereby suppressing 
glycolysis and production of interleukins 1β, 6 and 12, and 
increases bacterial burden.16
There is certainly much uncertainty concerning the possible 
biological role of hydrogen sulfide and our abilities to prevent 
or treat human diseases by an intervention to its metabolism. 
However, it seems to be a new and promising field which may 
prove more interesting in the future.
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